疑似与皮里多斯提格相关的肝毒性
Laura DiBenedetto1, Vincent Wong2, Umair Nasir3
1Department of Internal Medicine, NYU Langone - Long Island, Mineola, NY.
药物诱导的肝损伤可能来自药物. 这一案例突出了Ogilvie综合征使用的药物pyridostigmine引起的肝损伤,强调了考虑药物毒性的重要性.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 临床药理学 临床药理学
背景情况:
- 药物诱导性肝损伤 (DILI) 是由药物或其代谢物引起的肝损伤.
- DILI是一种排除诊断,需要排除其他肝损伤原因,如感染或自身免疫性疾病.
- 在药物暴露和肝脏症状之间建立时间联系有助于识别致病原体.
研究的目的:
- 为了呈现皮里多斯蒂格使用后的肝损伤病例.
- 讨论急性结肠伪阻塞 (奥吉尔维综合征) 的管理.
主要方法:
- 病例报告详细介绍患者的表现和临床过程.
- 关于药物诱导的肝损伤和pyridostigmine毒性的文献综述.
主要成果:
- 患者患有肝脏损伤,这种损伤归因于pyridostigmine.
- 止 pyridostigmine 导致肝损伤的解决.
结论:
- 皮里多斯提格明可以引起药物诱导的肝损伤.
- 仔细考虑药物历史对于诊断肝损伤至关重要,特别是在患有像奥吉尔维综合征这样的疾病的患者中.
更多相关视频
06:29Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
Published on: June 11, 2019
09:32Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
Published on: October 17, 2025
相关概念视频
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Drug Toxicity: Risk factors
Drug Toxicity: Dose-Dependent Reactions
Drug toxicity: Idiosyncratic Reactions
